Journal: Journal of CME

Article Title: Healthcare Disparities: Encouraging Change Through Continuing Professional Development

doi: 10.1080/28338073.2023.2269075

Figure Lengend Snippet: CPD programmes and associated learning objective.

Article Snippet: Myelodysplastic Syndromes: Guidance on the Optimal Management of Older Adult Patients , Bristol Myers Squibb. Provided by Rush University Medical Center partnership with the MDS Foundation..

Techniques: Diagnostic Assay

Journal: Journal of CME

Article Title: Healthcare Disparities: Encouraging Change Through Continuing Professional Development

doi: 10.1080/28338073.2023.2269075

Figure Lengend Snippet:

Article Snippet: Myelodysplastic Syndromes: Guidance on the Optimal Management of Older Adult Patients , Bristol Myers Squibb. Provided by Rush University Medical Center partnership with the MDS Foundation..

Techniques:

Journal: PLoS ONE

Article Title: Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs

doi: 10.1371/journal.pone.0235021

Figure Lengend Snippet: Reported drug industry funding of patient organisations in Sweden across condition and disease areas (2014–18).

Article Snippet: Of uncertain behavior, polycythemia vera and myelodysplastic syndromes , D37-D48 , 81 847 (3.4) , 8 (1.3) , 2 , Novartis, 70 718 (86.4).

Techniques:

Journal: Journal of medicinal chemistry

Article Title: Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development

doi: 10.1021/acs.jmedchem.0c01487

Figure Lengend Snippet: Pan-BET Inhibitors in Cancer-Related Clinical Trials a

Article Snippet: , Plexxikon , I , solid tumors, AML, myelodysplastic syndrome, NHL , NCT02683395 , terminated.

Techniques: Clinical Proteomics

Journal: Blood Advances

Article Title: Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients

doi: 10.1182/bloodadvances.2020003976

Figure Lengend Snippet: Molecular characteristics and survival outcomes in patients with clonal cytopenias of undetermined significance, lower-risk myelodysplastic syndromes, and lower-risk chronic myelomonocytic leukemia. (A) Split bean plot demonstrating the 6 most common mutations in both CCUS and LR-MDS and their respective VAFs. (B) Bar graph of CCUS and LR-MDS demonstrating the 10 most frequent mutations in all 188 patients and the percentage of patients with that mutation. (C) Kaplan-Meier OS estimate in CCUS and LR-MDS patients, censored at 10 years of follow-up. (D) Kaplan-Meier leukemia-free survival estimate in CCUS, LR-MDS, and LR-CMML patients, censored at 10 years of follow-up. (E) Distribution of survival and progression outcomes in LR-MDS, LR-CMML, and CCUS patients.

Article Snippet: The authors thank the Mayo Clinic Center for Individualized Medicine for sponsoring the clonal hematopoiesis clinic and the Henry J. Predolin leukemia fund for developing the myelodysplastic syndrome/acute myeloid leukemia biorepository.

Techniques: Mutagenesis

Journal: Leukemia Research Reports

Article Title: Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning

doi: 10.1016/j.lrr.2022.100328

Figure Lengend Snippet: Top 5 Animations and Top 10 Expert Videos by Frequency.

Article Snippet: You and MDS: An Animated Patient's Guide to Myelodysplastic Syndromes is supported by unrestricted education grants from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.

Techniques: Biomarker Discovery, Transplantation Assay

Journal: Leukemia Research Reports

Article Title: Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning

doi: 10.1016/j.lrr.2022.100328

Figure Lengend Snippet: Top 5 Animations and Top 10 Expert Videos by Highest Retention Viewed.

Article Snippet: You and MDS: An Animated Patient's Guide to Myelodysplastic Syndromes is supported by unrestricted education grants from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.

Techniques: Biomarker Discovery

Journal: Leukemia Research Reports

Article Title: Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning

doi: 10.1016/j.lrr.2022.100328

Figure Lengend Snippet: Top 5 Animations and Top 10 Expert Videos by Frequency.

Article Snippet: You and MDS: An Animated Patient's Guide to Myelodysplastic Syndromes is supported by unrestricted education grants from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.

Techniques: Biomarker Discovery, Transplantation Assay

Journal: Leukemia Research Reports

Article Title: Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning

doi: 10.1016/j.lrr.2022.100328

Figure Lengend Snippet: Top 5 Animations and Top 10 Expert Videos by Highest Retention Viewed.

Article Snippet: You and MDS: An Animated Patient's Guide to Myelodysplastic Syndromes is supported by unrestricted education grants from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.

Techniques: Biomarker Discovery